Skip to main content

ADC Therapeutics SA

ADCT
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001771910

No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding ADC Therapeutics SA changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of ADCT: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders5956−3
Shares46.6M45.4M−1.25M (−2.7%)
Value$90.9M$97.5M+$6.63M (+7.3%)

New holders (10)

Institutions that held ADC Therapeutics SA at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to ADCT in Q2 2023
InstitutionSharesValue% of portfolio
Laurion Capital Management LP120,881$259.9K0.01%
Miracle Mile Advisors, LLC84,496$181.7K0.01%
Acadian Asset Management LLC21,862$45.0K0.00%
Virtu Financial LLC18,835$40.0K0.00%
ELCO Management Co., LLC11,799$25.4K0.02%
Evergreen Capital Management LLC11,000$23.6K0.00%
Cypress Capital Group10,000$21.5K0.00%
Aquatic Capital Management LLC2,300$5.00K0.00%
Citigroup Inc1,834$3.94K0.00%
Northwestern Mutual Wealth Management Co100$2150.00%

Sold out (13)

Institutions that held ADC Therapeutics SA at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of ADCT in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Eventide Asset Management, LLC1,675,959$3.27M
Perceptive Advisors LLC1,495,805$2.92M
Two Sigma Investments, LP223,827$436.5K
Woodline Partners LP143,403$279.6K
Fred Alger Management, LLC125,985$245.7K
Rockefeller Capital Management L.P.24,701$48.0K
HRT Financial LP16,334$31.0K
IHT Wealth Management, LLC15,110$29.5K
Dynamic Technology Lab Private Ltd14,332$28.0K
Values First Advisors, Inc.13,019$25.4K
Prospera Financial Services Inc12,623$24.6K
UBS Group AG11,302$22.0K
Commonwealth Equity Services, LLC10,093$19.0K